intratumoral STING receptor agonist
in Ph. I for adv. solid tumors as single agent
from macrocyclization of cyclic dinucleotide
ChemMedChem., Jan. 31, 2021
Eisai Inc., Cambridge, MA
E7766 (STING)
1 min read
3. The Eisai STING agonist E7766 leads to tumor eradication in 9/10 treated animals in a syngeneic model when injected intratumorally, and is currently in a Ph. I study for advanced solid tumors. The molecule has an interesting macrocyclic structure, and behaves as a cyclic dinucleotide mimic with potent activity on all four human STING variants.
Search By Structure
- CC-90009
- LYS006
- E7766 (STING)
- Mobocertinib (TAK-788)
- TAK-981
- “compound 24”
- ARB-272572
- EC5026
- Atabecestat (JNJ-54861911)
- HSK16149
- M5049
- CPI-1328
- SJF-0628
- NITD-688
Molecules of the Month
2023
2022
2021
2020